CVE:ACST Acasti Pharma - ACST Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$0.92 +0.06 (+6.98%) (As of 02/2/2023 05:20 PM ET) Add Compare Share Share Today's RangeC$0.91▼C$0.9250-Day RangeC$0.47▼C$1.1252-Week RangeC$0.47▼C$1.66Volume2,300 shsAverage Volume9,600 shsMarket CapitalizationC$41.04 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlines About Acasti Pharma (CVE:ACST) StockAcasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.Read More Receive ACST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address ACST Stock News HeadlinesJanuary 13, 2023 | benzinga.comAcasti Pharma to Present at Sidoti Virtual Investor Conference on January 18November 15, 2022 | seekingalpha.comAcasti Pharma Inc. (ACST) Q2 2023 Earnings Call TranscriptFebruary 2, 2023 | Investing Trends (Ad)The Biggest "Missing Ingredient" in the $7 Trillion EV MarketChina has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market.November 9, 2022 | it.tmcnet.comAcasti Pharma to Present at Q4 Investor SummitNovember 8, 2022 | tmcnet.comAcasti Pharma to Report Second Quarter 2023 FinancialSeptember 17, 2022 | theglobeandmail.comAcasti Pharma: Top 10 Undervalued Biotechnology Industry Sector Stocks on TSX Venture Exchange (ACST)September 14, 2022 | finance.yahoo.comAcasti Pharma to Participate in the Lytham Partners Fall 2022 Investor ConferenceSeptember 13, 2022 | it.tmcnet.comAcasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-102, the Company's Drug Candidate for the Treatment of Ataxia TelangiectasiaFebruary 2, 2023 | Investing Trends (Ad)The Biggest "Missing Ingredient" in the $7 Trillion EV MarketChina has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market.July 27, 2022 | finance.yahoo.comAcasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic NeuralgiaJuly 9, 2022 | finanznachrichten.deStock Day Media: Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day PodcastJuly 7, 2022 | finance.yahoo.comAcasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day PodcastJune 21, 2022 | seekingalpha.comAcasti Pharma, Inc. (ACST) CEO Jan D'Alvise on Q4 2022 Results - Earnings Call TranscriptJune 21, 2022 | seekingalpha.comAcasti Pharma reports GAAP EPS of $0.27 for FY2022May 12, 2022 | apnews.comAcasti Pharma CEO to Present at Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16thMarch 9, 2022 | finance.yahoo.comAcasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16thFebruary 7, 2022 | finance.yahoo.comAcasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference CallDecember 22, 2021 | benzinga.comThinking about buying stock in Naked Brand, Biondvax Pharmaceuticals, eMagin Corp, Red Cat, or Acasti Pharma?November 24, 2021 | finance.yahoo.comAcasti Pharma CEO to Participate in the Benzinga All Access Event on December 2ndNovember 4, 2021 | finance.yahoo.comAcasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference CallOctober 8, 2021 | proactiveinvestors.comAcasti Pharma outlines key benefits of recent Grace Therapeutics acquisitionOctober 6, 2021 | finance.yahoo.comAcasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in JapanSeptember 29, 2021 | benzinga.comAcasti Pharma Announces Initiation Of Pharmacokinetic Bridging Study For GTX-104August 31, 2021 | msn.comWhy Shares of Acasti Pharma Slumped TuesdayAugust 28, 2021 | benzinga.comAcasti Says 8-For-1 Reverse Stock Split Will Be implemented To Help Regain Nasdaq ComplianceJuly 6, 2021 | ca.finance.yahoo.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Acasti Pharma Inc. MergerJuly 3, 2021 | markets.businessinsider.comSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acasti Pharma, Inc. - ACSTSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ACST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address ACST Company Calendar Today2/02/2023Next Earnings (Estimated)2/13/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:ACST Previous SymbolCVE:APO CUSIPN/A CIKN/A Webwww.acastipharma.com Phone+1-450-6864555FaxN/AEmployees32Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.52 Current Ratio9.86 Quick Ratio9.41 Sales & Book Value Annual SalesC$115,000.00 Price / Sales356.90 Cash FlowC$1.47 per share Price / Cash Flow0.63 Book ValueC$2.25 per share Price / Book0.41Miscellaneous Outstanding Shares44,613,000Free FloatN/AMarket CapC$41.04 million OptionableNot Optionable BetaN/A Key ExecutivesMs. Janelle D'Alvise (Age 68)Pres, CEO, Corp. Sec. & Director Comp: $620.16kDr. Pierre Lemieux M.D. (Age 58)Ph.D., Co-Founder, COO & Chief Scientific Officer Comp: $398.75kMr. Brian D. Ford CPA (Age 64)CA, Chief Financial Officer Comp: $340.84kDr. George Kottayil (Age 60)Chief Operating Officer of US Comp: $160.16kMr. Prashant KohliChief Commercial OfficerDr. Yves Lachance Ph.D.VP of Quality & ComplianceMs. Christine PelletierSr. Director of HRMore ExecutivesKey CompetitorsHelix BioPharmaTSE:HBPSmall PharmaCVE:DMTIMVTSE:IMVDevonian Health GroupCVE:GSDResverlogixTSE:RVXView All Competitors ACST Stock - Frequently Asked Questions How have ACST shares performed in 2023? Acasti Pharma's stock was trading at C$0.75 at the start of the year. Since then, ACST shares have increased by 22.7% and is now trading at C$0.92. View the best growth stocks for 2023 here. When is Acasti Pharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 13th 2023. View our ACST earnings forecast. What other stocks do shareholders of Acasti Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acasti Pharma investors own include Matinas BioPharma (MTNB), Aurora Cannabis (ACB), SCYNEXIS (SCYX), Block (SQ), Nokia Oyj (NOK), Axsome Therapeutics (AXSM), Blink Charging (BLNK), Inovio Pharmaceuticals (INO), Okta (OKTA) and Tesla (TSLA). What is Acasti Pharma's stock symbol? Acasti Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ACST." How do I buy shares of Acasti Pharma? Shares of ACST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Acasti Pharma's stock price today? One share of ACST stock can currently be purchased for approximately C$0.92. How much money does Acasti Pharma make? Acasti Pharma (CVE:ACST) has a market capitalization of C$41.04 million and generates C$115,000.00 in revenue each year. How can I contact Acasti Pharma? Acasti Pharma's mailing address is 545 Prom du Centropolis Suite 100, LAVAL, QC H7T 0A3, Canada. The official website for the company is www.acastipharma.com. The company can be reached via phone at +1-450-6864555. This page (CVE:ACST) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.